American Well Corp (AMWL) — SEC Filings

Latest SEC filings for American Well Corp (AMWL), explained in plain English.

Sentiment Overview: 1 bearish, 33 neutral

Recent Filings (34)

• 10-Q Filing — 10-Q · 2025-11-04T00:00:00.000Z [neutral]
• American Well Corp Files Q2 2025 10-Q — 10-Q · 2025-08-05T00:00:00.000Z [neutral] Risk: medium
  American Well Corp filed its 10-Q for the period ending June 30, 2025. The filing details the company's financial performance and operational status. Key financ
• Amwell Reports Security Holder Vote on June 11 — 8-K · 2025-06-17T00:00:00.000Z [neutral] Risk: low
  American Well Corporation (Amwell) filed an 8-K on June 17, 2025, reporting on a matter submitted to a vote of its security holders on June 11, 2025. The filing
• American Well Corp Files Q1 2025 10-Q — 10-Q · 2025-05-01T00:00:00.000Z [neutral] Risk: medium
  American Well Corp filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and operational updates. Key fina
• American Well Corp Executive Compensation Filing — DEF 14A · 2025-04-23T00:00:00.000Z [neutral] Risk: low
  American Well Corp (AMWL) filed its DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing include
• American Well Corp Files 8-K on Officer/Director Changes — 8-K · 2025-03-03T00:00:00.000Z [neutral] Risk: low
  American Well Corporation filed an 8-K on March 3, 2025, reporting events as of February 25, 2025. The filing pertains to the departure of directors or certain
• American Well Corp Files 2024 10-K — 10-K · 2025-02-12T00:00:00.000Z [neutral] Risk: medium
  American Well Corp filed its 2024 10-K on February 12, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Boston, MA, op
• Amwell Announces Material Definitive Agreement — 8-K · 2025-01-10T00:00:00.000Z [neutral] Risk: medium
  On January 8, 2025, American Well Corporation (Amwell) entered into a material definitive agreement related to the completion of an acquisition or disposition o
• Amwell Reports Board Changes and Compensation Updates — 8-K · 2024-12-18T00:00:00.000Z [neutral] Risk: medium
  American Well Corporation (Amwell) filed an 8-K on December 17, 2024, reporting changes in its board of directors and executive compensation arrangements. The f
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-11-06T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-04T00:00:00.000Z [neutral]
• American Well Corp: Director Changes and Officer Appointments — 8-K · 2024-10-31T00:00:00.000Z [neutral] Risk: low
  On October 25, 2024, American Well Corporation filed an 8-K report. The filing primarily concerns the departure of a director, the election of new directors, an
• American Well Corp Files Q3 2024 10-Q — 10-Q · 2024-10-30T00:00:00.000Z [neutral] Risk: medium
  American Well Corp (AMWL) filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the thir
• Amwell Board Changes and Compensation Updates — 8-K · 2024-10-15T00:00:00.000Z [neutral] Risk: medium
  American Well Corporation (Amwell) announced on October 11, 2024, a change in its board of directors. Specifically, the company reported the departure of a dire
• Amwell Relocates Principal Executive Offices — 8-K · 2024-08-22T00:00:00.000Z [neutral] Risk: low
  American Well Corporation (Amwell) announced on August 16, 2024, a change in its principal executive offices to 75 State Street, 26th Floor, Boston, MA 02109. T
• American Well Corp Q2 2024 10-Q Filing — 10-Q · 2024-07-31T00:00:00.000Z [neutral] Risk: medium
  American Well Corp (AMWL) filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second qu
• Amwell Sells Telehealth Business to Teladoc for $1.1B — 8-K · 2024-07-16T00:00:00.000Z [neutral] Risk: medium
  American Well Corporation (Amwell) announced on July 10, 2024, that it has entered into a definitive agreement to sell its telehealth services business to Telad
• SC 13G/A Filing — SC 13G/A · 2024-07-08T00:00:00.000Z [neutral]
• American Well Corp Files 8-K — 8-K · 2024-07-01T00:00:00.000Z [neutral] Risk: low
  On June 27, 2024, American Well Corporation (AMWL) filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements and exh
• American Well Corp (AMWL) Schedules Shareholder Vote — 8-K · 2024-06-24T00:00:00.000Z [neutral] Risk: low
  On June 18, 2024, American Well Corporation (AMWL) filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicat
• Amwell Announces Executive Compensation and Director Changes — 8-K · 2024-06-17T00:00:00.000Z [neutral] Risk: medium
  American Well Corporation (Amwell) announced on June 13, 2024, a change in its executive compensation structure. The company filed an 8-K report detailing the e
• American Well Corp. Appoints New Chief Medical Officer — 8-K · 2024-06-13T00:00:00.000Z [neutral] Risk: medium
  On June 13, 2024, American Well Corp. announced the appointment of Dr. Jennifer Schneider as Chief Medical Officer and the departure of Dr. Roy Schoenberg from
• American Well (AMWL) Q1 2024 10-Q Filed — 10-Q · 2024-05-01T00:00:00.000Z [neutral] Risk: medium
  American Well Corp (AMWL) filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates. Key disclosures
• American Well Corp DEF 14A: Executive Compensation Details — DEF 14A · 2024-04-26T00:00:00.000Z [neutral] Risk: medium
  American Well Corp (AMWL) filed its DEF 14A on April 26, 2024, detailing executive compensation and corporate governance matters. The filing includes informatio
• Amwell Faces Potential NYSE American Delisting Notice — 8-K · 2024-04-04T00:00:00.000Z [bearish] Risk: high
  American Well Corp. (Amwell) filed an 8-K on April 4, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The fili
• American Well Corp Files 2023 Annual Report Amendment — 10-K/A · 2024-03-01T00:00:00.000Z [neutral] Risk: medium
  American Well Corp filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. This filing provides updated information and d
• Amwell Files 2023 Annual Report with SEC — 10-K · 2024-02-15T00:00:00.000Z [neutral] Risk: medium
  American Well Corp (Amwell) filed its annual 10-K report on February 15, 2024, covering the fiscal year that ended on December 31, 2023. The filing mentions ent
• SC 13G/A Filing — SC 13G/A · 2024-02-14T00:00:00.000Z [neutral]
• American Well Corp Files 8-K on Financial Condition and Operations — 8-K · 2024-02-14T00:00:00.000Z [neutral] Risk: low
  American Well Corporation, a Delaware-incorporated company based in Boston, MA, filed an 8-K on February 14, 2024. The filing, under SEC File Number 001-39515,
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Ido Schoenberg Holds 11.0% Stake in American Well Corp — SC 13G/A · 2024-02-12T00:00:00.000Z [neutral] Risk: low
  Ido Schoenberg, a key figure at American Well Corp (AMWL), has updated his beneficial ownership of the company's Class A Common Stock. As of December 31, 2023,
• Senvest Management Updates Amwell Stake as of Dec 31, 2023 — SC 13G/A · 2024-02-09T00:00:00.000Z [neutral] Risk: low
  Senvest Management, LLC, a Delaware-organized investment firm, filed an amended SC 13G/A on February 9, 2024, indicating its ownership of American Well Corporat
• BlackRock Amends AMWL Stake, Maintains Passive Position — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership in American Well Corp (AMWL) as of December 31, 2023. This filing, an am